MSLN is also known to be overexpressed to a lesser extent in multiple other human cancers such as endometrial, lung, stomach, triple negative breast, cervical, non-small cell lung cancer (NSCLC) and head and neck cancers (HNSCC) [3–8]. Here, MSLN is linked to non-small cell lung carcinoma.